EP1877773A1 - Neue apparatur und verfahren zur beschichtung von trägersubstraten für einen analytnachweis mittels affinitäts-nachweisverfahren - Google Patents
Neue apparatur und verfahren zur beschichtung von trägersubstraten für einen analytnachweis mittels affinitäts-nachweisverfahrenInfo
- Publication number
- EP1877773A1 EP1877773A1 EP06724515A EP06724515A EP1877773A1 EP 1877773 A1 EP1877773 A1 EP 1877773A1 EP 06724515 A EP06724515 A EP 06724515A EP 06724515 A EP06724515 A EP 06724515A EP 1877773 A1 EP1877773 A1 EP 1877773A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- carrier substrates
- liquid
- atomized
- coating
- coated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000758 substrate Substances 0.000 title claims abstract description 242
- 238000000576 coating method Methods 0.000 title claims abstract description 137
- 238000000034 method Methods 0.000 title claims abstract description 117
- 238000001514 detection method Methods 0.000 title claims abstract description 93
- 239000011248 coating agent Substances 0.000 title claims abstract description 83
- 238000003556 assay Methods 0.000 title claims abstract description 24
- 239000012491 analyte Substances 0.000 title claims description 29
- 239000007788 liquid Substances 0.000 claims abstract description 132
- 238000002161 passivation Methods 0.000 claims abstract description 58
- 150000001875 compounds Chemical class 0.000 claims abstract description 29
- 230000008569 process Effects 0.000 claims abstract description 19
- 239000000126 substance Substances 0.000 claims abstract description 15
- 238000000889 atomisation Methods 0.000 claims abstract description 6
- 238000005259 measurement Methods 0.000 claims description 59
- 239000003595 mist Substances 0.000 claims description 56
- 239000000243 solution Substances 0.000 claims description 48
- 230000027455 binding Effects 0.000 claims description 36
- 230000005284 excitation Effects 0.000 claims description 23
- 230000009870 specific binding Effects 0.000 claims description 23
- 235000018102 proteins Nutrition 0.000 claims description 22
- 102000004169 proteins and genes Human genes 0.000 claims description 22
- 108090000623 proteins and genes Proteins 0.000 claims description 21
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 14
- 229940098773 bovine serum albumin Drugs 0.000 claims description 14
- 108020004414 DNA Proteins 0.000 claims description 11
- 238000002604 ultrasonography Methods 0.000 claims description 11
- 239000003153 chemical reaction reagent Substances 0.000 claims description 10
- 108091033319 polynucleotide Proteins 0.000 claims description 10
- 102000040430 polynucleotide Human genes 0.000 claims description 10
- 239000002157 polynucleotide Substances 0.000 claims description 10
- 230000001105 regulatory effect Effects 0.000 claims description 10
- 238000004020 luminiscence type Methods 0.000 claims description 9
- 230000001276 controlling effect Effects 0.000 claims description 8
- 239000012528 membrane Substances 0.000 claims description 8
- 230000007935 neutral effect Effects 0.000 claims description 8
- 229920001223 polyethylene glycol Polymers 0.000 claims description 8
- 238000009827 uniform distribution Methods 0.000 claims description 8
- 239000011159 matrix material Substances 0.000 claims description 7
- 108020004707 nucleic acids Proteins 0.000 claims description 7
- 102000039446 nucleic acids Human genes 0.000 claims description 7
- 150000007523 nucleic acids Chemical class 0.000 claims description 7
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 6
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 6
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 6
- 238000003860 storage Methods 0.000 claims description 6
- 102000009027 Albumins Human genes 0.000 claims description 5
- 108010088751 Albumins Proteins 0.000 claims description 5
- 241000972773 Aulopiformes Species 0.000 claims description 5
- 102000011632 Caseins Human genes 0.000 claims description 5
- 108010076119 Caseins Proteins 0.000 claims description 5
- 229920002307 Dextran Polymers 0.000 claims description 5
- 108091006905 Human Serum Albumin Proteins 0.000 claims description 5
- 102000008100 Human Serum Albumin Human genes 0.000 claims description 5
- 239000005018 casein Substances 0.000 claims description 5
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 5
- 235000021240 caseins Nutrition 0.000 claims description 5
- 239000003599 detergent Substances 0.000 claims description 5
- 239000000284 extract Substances 0.000 claims description 5
- 238000009396 hybridization Methods 0.000 claims description 5
- 229920001477 hydrophilic polymer Polymers 0.000 claims description 5
- 238000003018 immunoassay Methods 0.000 claims description 5
- 235000019515 salmon Nutrition 0.000 claims description 5
- 150000004756 silanes Chemical class 0.000 claims description 5
- 241000252203 Clupea harengus Species 0.000 claims description 4
- 108091034117 Oligonucleotide Proteins 0.000 claims description 4
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 4
- 230000001476 alcoholic effect Effects 0.000 claims description 4
- -1 alkyl phosphates Chemical class 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 238000000151 deposition Methods 0.000 claims description 4
- 230000008021 deposition Effects 0.000 claims description 4
- 235000019514 herring Nutrition 0.000 claims description 4
- 229910019142 PO4 Inorganic materials 0.000 claims description 3
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical class OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 claims description 3
- 229920001400 block copolymer Polymers 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 3
- 150000002118 epoxides Chemical class 0.000 claims description 3
- 235000021317 phosphate Nutrition 0.000 claims description 3
- 229920006112 polar polymer Polymers 0.000 claims description 3
- 229920000729 poly(L-lysine) polymer Polymers 0.000 claims description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 2
- 108091023037 Aptamer Proteins 0.000 claims description 2
- 102000004190 Enzymes Human genes 0.000 claims description 2
- 108090000790 Enzymes Proteins 0.000 claims description 2
- 102000002068 Glycopeptides Human genes 0.000 claims description 2
- 108010015899 Glycopeptides Proteins 0.000 claims description 2
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims description 2
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims description 2
- 108090001090 Lectins Proteins 0.000 claims description 2
- 102000004856 Lectins Human genes 0.000 claims description 2
- 241001465754 Metazoa Species 0.000 claims description 2
- 239000000427 antigen Substances 0.000 claims description 2
- 108091007433 antigens Proteins 0.000 claims description 2
- 102000036639 antigens Human genes 0.000 claims description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 2
- 238000010348 incorporation Methods 0.000 claims description 2
- 239000002523 lectin Substances 0.000 claims description 2
- 239000003446 ligand Substances 0.000 claims description 2
- 229920001542 oligosaccharide Polymers 0.000 claims description 2
- 150000002482 oligosaccharides Chemical class 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims description 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 2
- 238000012545 processing Methods 0.000 claims description 2
- 230000008093 supporting effect Effects 0.000 claims description 2
- 238000003786 synthesis reaction Methods 0.000 claims description 2
- 150000003573 thiols Chemical class 0.000 claims description 2
- 239000011230 binding agent Substances 0.000 claims 1
- 238000011084 recovery Methods 0.000 claims 1
- 239000010410 layer Substances 0.000 description 107
- 230000003287 optical effect Effects 0.000 description 28
- 239000000523 sample Substances 0.000 description 25
- 238000002493 microarray Methods 0.000 description 24
- 239000007789 gas Substances 0.000 description 22
- 238000007598 dipping method Methods 0.000 description 20
- 238000003491 array Methods 0.000 description 17
- 239000000463 material Substances 0.000 description 15
- 239000013592 cell lysate Substances 0.000 description 14
- 238000005507 spraying Methods 0.000 description 14
- 230000008878 coupling Effects 0.000 description 13
- 238000010168 coupling process Methods 0.000 description 13
- 238000005859 coupling reaction Methods 0.000 description 13
- 239000011521 glass Substances 0.000 description 13
- 239000010409 thin film Substances 0.000 description 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 10
- 239000007921 spray Substances 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 8
- 102100025064 Cellular tumor antigen p53 Human genes 0.000 description 7
- 229920000089 Cyclic olefin copolymer Polymers 0.000 description 7
- 239000004793 Polystyrene Substances 0.000 description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- 238000004113 cell culture Methods 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- 239000004033 plastic Substances 0.000 description 6
- 229920003023 plastic Polymers 0.000 description 6
- 229920002223 polystyrene Polymers 0.000 description 6
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 5
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 5
- 229960004679 doxorubicin Drugs 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 239000010408 film Substances 0.000 description 5
- 238000007654 immersion Methods 0.000 description 5
- 230000003993 interaction Effects 0.000 description 5
- 229910052751 metal Inorganic materials 0.000 description 5
- 239000002184 metal Substances 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 230000009871 nonspecific binding Effects 0.000 description 5
- 230000019491 signal transduction Effects 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 239000004642 Polyimide Substances 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 229910010413 TiO 2 Inorganic materials 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 4
- 239000012131 assay buffer Substances 0.000 description 4
- 150000001925 cycloalkenes Chemical class 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000001917 fluorescence detection Methods 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 239000007791 liquid phase Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000002663 nebulization Methods 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 4
- 239000004417 polycarbonate Substances 0.000 description 4
- 229920000515 polycarbonate Polymers 0.000 description 4
- 229920001721 polyimide Polymers 0.000 description 4
- 239000010453 quartz Substances 0.000 description 4
- 150000004760 silicates Chemical class 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 4
- 229920006352 transparent thermoplastic Polymers 0.000 description 4
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000013068 control sample Substances 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 210000001822 immobilized cell Anatomy 0.000 description 3
- 239000006166 lysate Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 230000026731 phosphorylation Effects 0.000 description 3
- 238000006366 phosphorylation reaction Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- 238000009757 thermoplastic moulding Methods 0.000 description 3
- 229910021642 ultra pure water Inorganic materials 0.000 description 3
- 239000012498 ultrapure water Substances 0.000 description 3
- 229910052581 Si3N4 Inorganic materials 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- TVACALAUIQMRDF-UHFFFAOYSA-N dodecyl dihydrogen phosphate Chemical compound CCCCCCCCCCCCOP(O)(O)=O TVACALAUIQMRDF-UHFFFAOYSA-N 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002073 fluorescence micrograph Methods 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 230000003100 immobilizing effect Effects 0.000 description 2
- 229910044991 metal oxide Inorganic materials 0.000 description 2
- 150000004706 metal oxides Chemical class 0.000 description 2
- 239000013307 optical fiber Substances 0.000 description 2
- BPUBBGLMJRNUCC-UHFFFAOYSA-N oxygen(2-);tantalum(5+) Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[Ta+5].[Ta+5] BPUBBGLMJRNUCC-UHFFFAOYSA-N 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 238000004064 recycling Methods 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- HQVNEWCFYHHQES-UHFFFAOYSA-N silicon nitride Chemical compound N12[Si]34N5[Si]62N3[Si]51N64 HQVNEWCFYHHQES-UHFFFAOYSA-N 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- PBCFLUZVCVVTBY-UHFFFAOYSA-N tantalum pentoxide Inorganic materials O=[Ta](=O)O[Ta](=O)=O PBCFLUZVCVVTBY-UHFFFAOYSA-N 0.000 description 2
- 238000013022 venting Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000012114 Alexa Fluor 647 Substances 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 241000270322 Lepidosauria Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
- 108091093078 Pyrimidine dimer Proteins 0.000 description 1
- 108010078814 Tumor Suppressor Protein p53 Proteins 0.000 description 1
- 102000015098 Tumor Suppressor Protein p53 Human genes 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 230000000274 adsorptive effect Effects 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000003782 apoptosis assay Methods 0.000 description 1
- 208000013715 atelosteogenesis type I Diseases 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000005415 bioluminescence Methods 0.000 description 1
- 230000029918 bioluminescence Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000005754 cellular signaling Effects 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 238000005401 electroluminescence Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 102000034356 gene-regulatory proteins Human genes 0.000 description 1
- 108091006104 gene-regulatory proteins Proteins 0.000 description 1
- 229920000578 graft copolymer Polymers 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 230000005661 hydrophobic surface Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000009830 intercalation Methods 0.000 description 1
- 230000002687 intercalation Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 229920000831 ionic polymer Polymers 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000009688 liquid atomisation Methods 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 238000000813 microcontact printing Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 239000006199 nebulizer Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000005522 programmed cell death Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008263 repair mechanism Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000001338 self-assembly Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000008054 signal transmission Effects 0.000 description 1
- 238000002444 silanisation Methods 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 1
- 238000010408 sweeping Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical class CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 230000004222 uncontrolled growth Effects 0.000 description 1
- 238000001429 visible spectrum Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B17/00—Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups
- B05B17/04—Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods
- B05B17/06—Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods using ultrasonic or other kinds of vibrations
- B05B17/0607—Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods using ultrasonic or other kinds of vibrations generated by electrical means, e.g. piezoelectric transducers
- B05B17/0615—Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods using ultrasonic or other kinds of vibrations generated by electrical means, e.g. piezoelectric transducers spray being produced at the free surface of the liquid or other fluent material in a container and subjected to the vibrations
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
Definitions
- a detection method based on bioaffinity reactions can be carried out both in a homogeneous solution and on the surface of a solid support ("carrier substrate").
- carrier substrate Depending on the specific structure of the method, after binding of the analytes to the corresponding recognition elements and optionally further detection substances and optionally between different Each step of the washing steps is necessary in order to separate the complexes formed from the recognition elements and the analytes to be detected and optionally further detection substances from the remainder of the sample and any additional reagents used.
- methods are used in which the detection of different analytes in discrete sample containers or "wells" of these plates takes place in so-called microtiter plates.
- an adhesion-promoting layer applied to the carrier substrate As suitable for the preparation of the primer layer, a variety of materials are known, for example, unfunctionalized or functionalized silanes, epoxides, functionalized, charged or polar polymers and "self-assembled passive or functionalized mono- or multilayers", alkyl phosphates and phosphonates, multifunctional block copolymers , such as poly (L) lysine / polyethylene glycols.
- coatings of bioanalytical sensor platforms or implants for medical applications are used as carrier substrates with graft copolymers as adhesion-promoting layer, with a polyionic main chain, for example binding to a carrier substrate (electrostatically), and non-interactive "(adsorption-resistant) side chains.
- these non-binding components may be known be selected from the groups of albumins, in particular bovine serum albumin or human serum albumin, casein, unspecific, polyclonal or monoclonal, non-specific or empirical for the analyte or antibodies to be detected non-specific antibodies (especially for immunoassays), detergents - such as Tween 20 -, not with to be analyzed polynucleotides hybridizing, fragmented natural or synthetic DNA, such as an extract of herring or salmon sperm (especially for polynucleotide hybridization assays), or uncharged, but hydrophilic polymers, such as polyethylene glycols or dextranes.
- albumins in particular bovine serum albumin or human serum albumin, casein, unspecific, polyclonal or monoclonal, non-specific or empirical for the analyte or antibodies to be detected non-specific antibodies (especially for immunoassays), detergents - such as Tween 20 -, not with to be analyzed polynu
- the inventive method represents a further development of the spraying method described above, wherein the production of very fine liquid droplets for the inventive method in a preferred embodiment by ultrasound treatment.
- the coating apparatus used for this method comprises in a preferred embodiment a closed container with a holder for horizontal storage of the carrier substrates (based on the surface of the liquid to be atomized) and an underlying ultrasonic generator, which is immersed in the liquid to be atomized.
- the inventive method is characterized in that the droplets produced are substantially smaller than in the case of the spray process.
- a very dense fog is generated over the liquid to be atomized, which is evenly distributed in a preferred embodiment by turbulence using a weak additional nitrogen stream in the container, the container is preferably closed except for gas inlets and gas outlets.
- Fig. 1 shows schematically a coating apparatus according to the invention.
- Fig. 2 shows the geometry of an array of measurement areas with 12 different applied samples in a two-dimensional array (“microarray”) and a linear array of 6 arrays on a common carrier substrate.
- 3A-3C show the fluorescence signals of microarrays, wherein the free surfaces of the associated carrier substrates were passivated by means of different coating methods, in each case with enlargements of the marked image sections underneath (A: dipping method, B: spraying method, C: nebulizing method according to the invention).
- FIG. 4A shows the mean values and standard deviations of the background signal intensities, which were respectively determined between all spots of the microarrays, wherein the free surfaces of the associated carrier substrates were passivated by means of different coating methods (A: dipping method, B: spraying method, C: nebulizing method according to the invention).
- 4B shows the mean values and standard deviations of the fluorescence intensities of all reference spots (for explanation, see in the exemplary embodiment) of the microarrays, wherein the free surfaces of the associated carrier substrates were passivated using different coating methods (A: dipping method, B: spraying method, C: nebulizing method according to the invention).
- 5A shows the averaged intensities and standard deviations of the fluorescence signals from the measuring ranges of the microarrays intended for analyte detection, wherein the free surfaces of the associated carrier substrates were passivated using different coating methods (A: dipping method, B: spraying method, C: nebulisation method according to the invention) and the microarrays afterwards with solutions of the antibody Al (anti-p53) and then each incubated for detection by fluorescence detection with Alexa 647 fluorine anti-rabbit Fab fragments.
- A dipping method
- B spraying method
- C nebulisation method according to the invention
- 5B shows the average intensities and standard deviations of the fluorescence signals from the measuring ranges of the microarrays intended for analyte detection, wherein the free surfaces of the associated carrier substrates were passivated using different coating methods (A: dipping method, B: spraying method, C: nebulizing method according to the invention) and the microarrays afterwards with solutions of antibody A2 (anti-phospho-p53) and then each incubated for detection by fluorescence detection with Alexa 647 fluorine anti-rabbit Fab fragments.
- A dipping method
- B spraying method
- C nebulizing method according to the invention
- the first object of the present invention is an apparatus for coating carrier substrates for detecting one or more analytes in an affinity detection method, comprising:
- liquid to be atomized is to be understood as the total amount of liquid within the coating apparatus according to the invention, to which the pulses of the actuator act to atomize the liquid, with the consequence of the conversion of a part of this liquid into mist.
- the generation of the mist above the liquid to be atomized is effected by the action of ultrasound within that liquid. Accordingly, it is preferred that said actuator serves to generate ultrasound.
- said actuator comprises the membrane of an ultrasonic generator.
- the uniformity and high homogeneity of the layer to be produced is of utmost importance.
- simple, commercial nebulizers such as those used primarily in terrarium, but must also be expected with the occurrence of large drops or even splashes from the liquid to be atomized.
- the coating apparatus comprises a droplet separator.
- This droplet separator is to be arranged in the volume of space between the surface of the liquid to be atomized and the holder on which the carrier substrates to be coated are stored during the coating process.
- a mist eliminator to be used may be impermeable to vapor and mist (for example, if the mist eliminator is a closed solid). It may be advantageous if the mist eliminator has the geometric shape of a concave mirror. For example, a watch glass (having a concave surface) may be used as a mist eliminator.
- the carrier substrates are coated during storage in the holder during the coating process on its side facing away from the surface of the liquid to be atomized / surface, wherein a coating on other surfaces must not be excluded.
- a coating apparatus in a coating method according to the invention to produce geometrically structured coatings by optionally sequential atomization of one or more optionally different liquids.
- the prerequisite for producing reproducible coated regions on the carrier substrates in their geometry is that areas of the carrier substrate that are not to be coated in each case are covered fluidically by a corresponding suitable mask, so that no mist droplets reach the areas not to be coated.
- the coating apparatus additionally comprises at least one gas inlet.
- the apparatus may additionally include one or more outlets for venting gas and / or mist.
- said provisions for producing a uniform distribution of the generated mist to be deposited on the carrier substrates in the vicinity of said carrier substrates comprise a ventilator with which the generated mist and, if appropriate, additional gases introduced into the container of the apparatus are fluidized to achieve a better mixing and thus elimination of inhomogeneities of the mist distribution.
- the coating apparatus additionally comprises provisions for controlling and / or regulating the temperature of the liquid to be atomized and / or one or all walls of the liquid container. It is also preferred that the holder of the coating apparatus for receiving and / or storing the carrier substrates during the coating process is thermostatable.
- the coating apparatus additionally comprises provisions for controlling and / or regulating the pressure within the liquid container during the coating process.
- the coating apparatus according to the invention additionally nebulizes provisions for collecting and recycling / recycling on the walls of the liquid container Liquid includes.
- the coating apparatus additionally comprises provisions to facilitate the cleaning of the liquid container.
- the provisions may include a hydrophobic coating on the surface of said container walls, both for recirculation to the inner walls of the liquid container and liquid to be atomized, and for ease of cleaning.
- Such provisions may also relate to the geometric shape, for example, by corners are avoided in which liquid can collect and is difficult to remove again, or at least rounded.
- the carrier substrates to be coated are stored substantially horizontally in the holder of the coating apparatus.
- essentially horizontal deviations of up to +/- 10 ° from a horizontal bearing should be included.
- the coating apparatus additionally comprises provisions for the controlled adjustment and / or variation of the distance between the surface of the liquid to be atomized and surfaces of the carrier substrates to be coated.
- the liquid container is closed except for optional gas inlet and optional additional gas and / or mist outlets.
- the liquids to be atomized are low-viscosity liquids having a viscosity of less than 3 cP. In particular, this may be act aqueous solutions. However, the liquids to be atomized may also be organic, in particular alcoholic solutions.
- the carrier substrates to be coated are substantially planar.
- the term "essentially planar” should be understood to mean that said carrier substrates comprise a plane in which, apart from a possibly existing three-dimensional structure (such as side walls of sample containers to be provided on the carrier substrate surface), the surface to be coated is located to substantially parallel second plane in which the opposite surface of the carrier substrates is located, wherein under the name “substantially parallel” deviations of up to +/- 10 ° of parallelism are included.
- substantially planar carrier substrates with both smooth and rough surfaces to be coated are to be understood.
- the carrier substrates to be coated may consist of a single (self-supporting) layer, such as. As glass slides, or even of several layers.
- At least one layer of the carrier substrates to be coated in the propagation direction of an irradiated excitation light or measurement light is substantially optically transparent.
- optical transparency of a material or of a carrier substrate should be understood to mean that the run length of a light propagating in said material or in said carrier substrate or in the (high-index) waveguiding film of a carrier substrate (see below) as optical waveguide is at least is a portion of the visible spectrum (between 400 nm and 750 nm) greater than 2 mm, provided that this run length is not limited by structures for changing the propagation direction of said light, for example, the run length of optically visible light, ie the distance on the path of the Light in the corresponding material, until the light intensity decreases to a value 1 / e of the intensity of origin when the light enters this material, on the order of several centimeters (eg in thin-film waveguides, see below) up to meters or kilometers (in Trap of optical fiber n for the optical signal transmission).
- the propagation length of an in of the waveguiding layer guided light by a decoupling diffractive grating are limited to a few microns.
- this limitation of the run length is due to the structuring, and not by the material properties of the structure.
- such a lattice waveguide structure is to be referred to as "optically transparent.”
- support structures or “layers that are substantially optically transparent” are to be understood as meaning the intensity of a support substrate or layers transmitted light by less than 50%.
- the support substrates to be coated comprise a thin metal layer, preferably of gold or silver, optionally on an underlying intermediate layer with refractive index preferably ⁇ 1.5, wherein the thickness of the metal layer and the possible intermediate layer are selected such that a microwavenplasmon at the wavelength of an incident excitation light and / or at the wavelength of a generated luminescence can be excited.
- the thickness of the metal layer is preferably between 10 nm and 1000 nm, more preferably between 30 nm and 200 nm.
- luminescence in this application refers to the spontaneous emission of photons in the ultraviolet to infrared range after optical or non-optical, such as electrical or chemical or biochemical or thermal excitation.
- chemiluminescence, bioluminescence, electroluminescence and in particular fluorescence and phosphorescence are included under the term “luminescence”. Fluorescence and phosphorescence are particularly preferred forms of luminescence.
- Optical waveguides are particularly well suited as a carrier substrate for analyte detection in an affinity detection method, since waveguiding combines the formation of a so-called "evanescent" field at the interfaces of the high-refractive-wave waveguiding layer with the adjacent layers (which may also be air) with lower refractive index
- the penetration depth of this evanescent field into the environment is limited to dimensions less than the wavelength of the guided light (eg, 200 nm to 400 nm) such that interactions of analyte molecules or detection molecules or molecular moieties (such as fluorescent labels ) with this evanescent field excited and observed spatially highly selectively on a surface of the waveguide and interference signals from the far field, eg., From the depth of a sample medium, can be largely excluded.
- the continuous or discrete waveguiding regions to be coated on the carrier substrates comprise a surface of the carrier substrates to be coated.
- the carrier substrates to be coated planar waveguide optical waveguide having a substantially optically transparent, waveguiding layer (a) on a second, also substantially optically transparent layer (b) having a lower refractive index than layer (a) and optionally also in Substantially optically transparent intermediate layer (b ') between layer (a) and layer (b) also with a lower refractive index than layer (a).
- the lower the layer thickness the greater the sensitivity up to a lower limit of the layer thickness.
- the lower limit value is determined by the termination of the light pipe when the value falls below a value which depends on the wavelength of the light to be led, as well as by an increase in the propagation losses in the case of very thin layers with further layer thickness decrease. It is preferred that the product of the thickness of the layer (a) and its refractive index is one tenth to one whole, preferably one third to two thirds, of the wavelength of an excitation light or measurement light to be coupled into the layer (a).
- the coupling via prisms which are preferably added to the waveguide without interstice or connected to the waveguide via a refractive index-matching liquid. It is also possible to introduce the excitation light via an optical fiber to the optical waveguide and to couple in via an end face or to couple the light coupled into another waveguide into the waveguide by bringing both waveguides close to each other such that their evanescent fields overlap and therewith Energy transfer can take place.
- the discrete or continuous waveguiding regions of the carrier substrates to be coated are in contact with one or more grating structures (c), which enable the coupling of excitation light or measuring light into waveguiding layers of said carrier substrates, and / or to one or more grating structures (c '), which enable the decoupling of excitation light or measuring light from waveguiding layers of said carrier substrates are, wherein in the case of simultaneously present on a carrier substrate grating structures (c) and (c') may have the same or different grating periods.
- Said lattice structures are preferably relief gratings of any desired profile, for example of rectangular, triangular, sawtooth, semicircular or sinusoidal profile, or of phase or volume gratings with a periodic modulation of the refractive index in the essentially planar layer (a ).
- grating structures (c) are formed as surface relief gratings.
- the grating structures (c) and / or (c ') may be mono- or multi-diffractive and have a depth of 2 nm-100 nm, preferably 10 nm-30 nm, and a period of 200 nm-1000 nm, preferably 300 nm - 700 nm, have.
- the ratio of the land width of the grid lines to the grating period may be between 0.01 and 0.99, with a ratio between 0.2 and 0.8 being preferred.
- Glass or quartz, transparent thermoplastic moldable or millable plastics for example polycarbonates, polyimides, acrylates, especially polymethyl methacrylates, polystyrenes, cyclo-olefin polymers and cyclo-olefin copolymers.
- Another object of the present invention is a method for coating carrier substrates for the detection of one or more analytes in an affinity detection method, characterized in that said to be coated carrier substrates in a holder of a coating apparatus according to the invention according to one of
- Liquid is fogged up and - From the generated mist, a deposition of substances contained in the nebulised liquid (compounds) on the carrier substrates to be coated takes place, wherein the carrier substrates in any contact with the surface to be nebulized
- Liquid are located.
- the generation of the mist above the liquid to be atomized is effected by the action of ultrasound within that liquid. Accordingly, it is preferred that said actuator serves to generate ultrasound.
- said actuator comprises the membrane of an ultrasonic generator and the atomization of liquid occurs by means of ultrasonic waves generated therein.
- said actuator is immersed in the operating state in liquid to be atomized.
- the actuator is completely within the liquid to be atomized.
- the coating apparatus comprises a droplet separator which prevents the contact of splashes and large droplets from the liquid to be atomized with the carrier substrates to be coated.
- a "large" drop is to be understood as meaning a drop with a diameter of more than 200 ⁇ m, whereby the mist eliminator may be impermeable to gas and mist, for example, the mist eliminator may be a closed solid
- a watch glass having a concave surface
- a mist eliminator to be used may also be permeable to drops up to a defined size. This can be technically realized, for example, by virtue of the fact that the mist eliminator comprises a fine-meshed net, with the mesh spacing of which the maximum size of drops to be passed is determined.
- the coating apparatus additionally comprises provisions for controlling and / or regulating the temperature of the liquid to be atomized and / or individual or all walls of the liquid container and the temperature of the nebulizing Liquid and / or single or all walls of the liquid container is controlled and / or varied during the coating process. It is also preferred that the holder of the coating apparatus for receiving and / or storing the carrier substrates is thermostated during the coating process.
- the carrier substrates during the coating process about an axis be rotated perpendicular to the mounting plane.
- a particular variant of the method according to the invention is characterized in that geometrically structured coatings are produced by optionally sequential atomization of one or more optionally different liquids using masks to be applied to the carrier substrates to be coated with a coating apparatus according to the invention.
- the prerequisite for the production of coated regions reproducible in their geometry on the carrier substrates is that areas of the carrier substrate which are not to be coated are covered in a fluid-tight manner by a suitable mask, so that no mist droplets reach the areas not to be coated.
- the carrier substrates to be coated are stored substantially horizontally during the coating process in the holder of the coating apparatus.
- the coating apparatus additionally comprises provisions for the controlled adjustment and / or variation of the distance between the surface of the liquid to be atomized and surfaces of the carrier substrates to be coated, and so that a well-defined distance between said liquid and the liquid surfaces to be coated for the period of the coating process is set.
- the liquid container of the coating apparatus is closed except for optional gas inlet and optional additional gas and / or mist outlets.
- the liquids to be atomized are low-viscosity liquids having a viscosity of less than 3 cP.
- these may be aqueous solutions.
- the liquids to be atomized may also be organic, in particular alcoholic solutions.
- the carrier substrates to be coated are substantially planar.
- the carrier substrates to be coated may consist of a single (self-supporting) layer, such as. As glass slides, or even of several layers.
- the carrier substrates to be coated comprise a thin metal layer, preferably of gold or silver, optionally on an underlying intermediate layer with refractive index preferably ⁇ 1.5, wherein the thickness of the metal layer and the possible intermediate layer are selected such that a microwavenplasmon at the wavelength of an incident excitation light and / or at the wavelength of a generated luminescence can be excited.
- the carrier substrates to be coated comprise optical waveguides comprising one or more layers.
- the carrier substrates may be formed throughout as optical waveguides or comprise discrete waveguiding regions.
- the carrier substrates to be coated planar waveguide optical waveguide having a substantially optically transparent, waveguiding layer (a) on a second, also substantially optically transparent layer (b) having a lower refractive index than layer (a) and optionally also in Substantially optically transparent intermediate layer (b ') between layer (a) and layer (b) also with a lower refractive index than layer (a).
- the discrete or continuous waveguiding regions of the carrier substrates to be coated can be brought into optical interaction with one or more optical coupling elements for coupling excitation or measuring light from one or more light sources during the detection step of an affinity detection method with said carrier substrates, wherein said optical coupling elements are selected from the group comprising prism couplers, evanescent couplers with matched optical waveguides with overlapping evanescent fields, face couplers with focusing lenses arranged in front of one waveguide layer of the carrier substrates, preferably cylindrical lenses, and grating couplers.
- the discrete or continuous waveguiding regions of the carrier substrates to be coated are in contact with one or more grating structures (c), which enable the coupling of excitation light or measuring light into waveguiding layers of said carrier substrates, and / or to one or more grating structures (c '), which enable the decoupling of excitation light or measuring light from waveguiding layers of said carrier substrates are, wherein in the case of simultaneously present on a carrier substrate grating structures (c) and (c') may have the same or different grating periods.
- the refractive index of the first optically transparent layer (a) is larger than 1.8. It is also preferable that the first optically transparent layer (a) comprises a material selected from the group consisting of silicon nitride, TiO 2 , ZnO, Nb 2 O 5 , Ta 2 O 5 , HfO 2 , and ZrO 2 , particularly preferably TiO 2 , Ta 2 O 5 or Nb 2 O 5 .
- the second optically transparent layer (b) of the carrier substrates to be coated comprises a material from the group consisting of silicates, for.
- silicates for.
- glass or quartz transparent thermoplastic molding, sprayable or millable plastics, such as polycarbonates, polyimides, acrylates, in particular polymethyl methacrylates, polystyrenes, cyclo-olefin polymers and cyclo-olefin copolymers.
- Characteristic of a preferred group of embodiments of the coating method according to the invention is that the carrier substrates to be coated enable the detection of one or more analytes in an affinity detection method by means of detection of one or more excited luminescences.
- the carrier substrates to be coated enable the detection of one or more analytes in an affinity detection method by means of detection of changes in the effective refractive index in the near field (evanescent field) on a surface of said carrier substrates.
- a group of embodiments of the method according to the invention is characterized in that the layer to be deposited on the carrier substrates is an adhesion-promoting layer.
- said adhesion promoting layer has a thickness of less than 200 nm, more preferably less than 20 nm.
- the primer layer may comprise a chemical compound from the groups comprising silanes, functionalized silanes, epoxides, functionalized charged or polar polymers, and "self-assembled passive or functionalized monolayers or multilayers", thiols, alkyl phosphates and phosphonates, multifunctional block copolymers, such as poly (L) lysine / polyethylene glycols.
- the method according to the invention is characterized in that one or more specific binding partners are immobilized on the surface of the carrier substrates for the detection of one or more analytes in an affinity detection method (binding the binding partner from a supplied solution to the immobilized binding partner).
- These specific binding partners can be applied to an adhesion-promoting layer applied by means of the coating method according to the invention or else directly to the uncoated surface of the carrier substrates, with areas of the surface remaining free of specific binding partners preferably being provided with a passivation layer in a subsequent coating step according to the method according to the invention below).
- the specific binding partners immobilized on the surface of said carrier substrates are biological or biochemical or synthetic recognition elements for the specific recognition of one or more analytes present in a sample supplied.
- different such specific recognition elements are present in each case in as highly pure a form as possible, generally in different discrete measurement ranges, so that different analytes from the sample generally bind to measurement regions with different recognition elements.
- Such arrays of measurement areas are also referred to as "capture arrays".
- Characteristic of a further widely applicable embodiment of the method according to the invention is therefore that the specific binding partners immobilized on the surface of said carrier substrates are the one or more analytes themselves, which are embedded in a native sample matrix or modified with one or more processing steps Form of the sample matrix are immobilized.
- Said binding partners i. the self-immobilized analyte to be detected or detected in a supplied sample and / or their immobilized or supplied in a supplied detection reagent biological or biochemical or synthetic Erkenuungs shame can be selected from the group which proteins, such as monoclonal or polyclonal antibodies and antibody fragments, peptides, enzymes , Glycopeptides, oligosaccharides, lectins, antigens for antibodies, proteins functionalized with additional binding sites ("tag proteins", such as "histidine tag proteins") and nucleic acids (for example DNA, RNA, oligonucleotides) and nucleic acid analogs (eg. PNA), aptamers, membrane-bound and isolated receptors and their ligands, cavities produced by chemical synthesis for incorporation of molecular imprints, natural and artificial polymers, etc.
- proteins such as monoclonal or polyclonal antibodies and antibody fragments, peptides, enzymes , Glycopeptides
- said specific binding partners applied to the surface of the carrier substrates can be immobilized in discrete measuring areas (spots) which can have any geometry, for example circular, oval, triangular, rectangular, polygonal, etc., wherein a single measuring area has identical or different specific binding partners may contain.
- albumins in particular bovine serum albumin or human serum albumin, casein, nonspecific, polyclonal or monoclonal, alien or empirical for the analyte (s) to be detected and / or their Binding partners non
- the present invention therefore relates to a method according to the invention according to one of the aforementioned embodiments, which is characterized in that the layer deposited on the carrier substrates is a passivation layer which is located between the spatially separated measuring areas or in unoccupied partial areas within these measuring areas
- Analytes and / or to its binding partners "chemically neutral" compounds after the generation of these measuring ranges is applied and preferably, for example, comprises compounds from the groups which albumin, especially bovine serum albumin or human serum albumin, casein, unspecific, polyclonal or monoclonal, alien or empirical for the or the analytes to be detected and their binding partners nonspecific antibodies (especially for immunoassays), detergents - such as Tween 20 -, do not hybridize with polynucleotides to be analyzed end, fragmented natural or synthetic DNA, such as extracts of herring or salmon sperm (especially for polynucleotide hybridization assays), or even uncharged but hydrophilic polymers, such as polyethylene glyco
- a further subject of the present invention is a carrier substrate for the detection of one or more analytes in an affinity detection method comprising an adhesion-promoting layer, characterized in that said adhesion-promoting layer is produced by a coating method according to the invention according to one of said embodiments.
- a carrier substrate for the detection of one or more analytes in an affinity detection method comprising a passivation layer covering the carrier substrate at least in partial regions, characterized in that said passivation layer is produced by a coating method according to the invention according to one of said embodiments.
- FIG. 1 A schematic representation of a coating apparatus according to the invention is shown in FIG. 1.
- the areas of unprotected areas of specific binding partners are to be "passivated” by carrier substrates prepared for an affinity detection method, i.e. a "passivation layer” is applied in these areas.
- the inventive apparatus in this exemplary embodiment comprises a desiccator (1) with a volume of about 2 1 as a container for the liquid to be atomized and the volume of mist to be generated over the liquid, a holder (2) for receiving the carrier substrates to be coated Ultrasonic atomizer ("Lucky Reptile Mini-Nebulizer", Reptilica, D-90431 Nuremberg, Germany) as an actuator (3) for liquid atomization, a watch glass as a droplet separator (4) and a gas inlet (5) and an outlet (6) for gas and / or generated fog.
- the ultrasonic generator mounted on the bottom of the desiccator was poured into polydimethylsiloxane (PDMS) just below the vibrating vibrating diaphragm, requiring only the application of a thin layer of fluid to be atomized is.
- PDMS polydimethylsiloxane
- the holder To be coated planar optical thin-film waveguides as carrier substrates, with the external dimensions of 14 mm wide x 57 mm long x 0.7 mm thick (for more details see below), in the holder (2) during the coating process at a distance of about 8 cm the liquid surface stored horizontally (with respect to the liquid surface).
- the holder is formed in the present example as a perforated carrier made of plastic, so that through these holes Excess liquid separated from the mist can flow off.
- the holder can accommodate ten thin-film waveguides as carrier substrates with the dimensions mentioned.
- the watch glass as a droplet is glued in the present example to the underside of the holder (2) and shields the substrates to be coated against splashes from the nebulizing solution (coating solution).
- the generated, very homogeneously distributed mist deposits on the carrier substrates, with in the present example on the top (with respect to the storage in the coating apparatus) arranged high-refractive wave-guiding layer (a), in the form of very small droplets, and already within 5 minutes to 10 Minutes forms on the tops of these substrates a thin, continuous liquid film.
- the carrier substrates are removed from the coating apparatus, thoroughly rinsed with flowing ultrapure water (Millipore) and finally dried in a stream of nitrogen.
- a volume of about 2 ml of passivation solution (liquid to be atomized) is required for a thin-film waveguide of the stated dimensions as the carrier substrate.
- the carrier substrates used for an affinity detection method to be carried out later are planar optical thin-film waveguides, each with the outer dimensions 14 mm wide x 57 mm long x 0.7 mm thick.
- These support substrates each comprise a glass substrate (AF 45) and a 150 nm thin, high refractive layer of tantalum pentoxide applied thereon.
- grating period: 318 nm, grating depth: (12 +/- 2) nm are modulated at a distance of 9 mm, which are to serve as diffractive gratings of the light coupling into the high refractive layer.
- a monolayer of mono-dodecyl phosphate (DDP) formed as an adhesion-promoting layer by spontaneous self-assembly (“soap assembly”) is applied hydrophobic bonding layer provided carrier substrates are each 6 identical microarrays of 144 discrete measuring areas (spots), in turn, in an array of 16 rows and 9 columns, with an inkjet spotter (model NP 1.2, GeSiM, Grosserkmannsdorf, Germany) applied is created by applying a single droplet of approximately 350 pL volume to the chip surface.
- DDP mono-dodecyl phosphate
- the analytes to be detected themselves are to be immobilized in a subsequent affinity detection method on the prepared carrier substrates, embedded in a native sample matrix or in a form of sample matrix (cell lysate) prepared with a few sample preparation steps. These forms of the samples are also referred to below as “nature-identical samples.”
- the detection step should then take place after addition of further detection reagents.
- a signaling pathway via a marker protein is the tumor suppressor protein p53, which via its degree of phosphorylation controls cell division, apoptosis and certain repair mechanisms for damaged DNA. These signaling pathways are often disturbed in cancer cells at one or more sites by mutations or lack of one or more marker proteins in their regulation, which may ultimately be responsible for uncontrolled growth.
- the detection and determination of the relative levels of p53 and P-p53 is performed by using highly specific antibodies that bind to these proteins, which directly act as analytes in the recovered and treated cell lysates the carrier substrates (preferably after application of a primer layer as described above) to be immobilized.
- each microarray contains further measurement areas with Cy5 fluorescently labeled bovine serum albumin (Cy5-BSA) immobilized therein, which are used to refer to local differences and / or temporal variations of the excitation light intensity during the measurement ("reference spots"). Cy5-BSA is applied in a concentration of 0.5 nM in 7 M urea, 2 M thiourea (labeling rate: about 3 Cy5 molecules per BSA molecule).
- FIG. 2 The geometry of the arrangement of the measurement areas in a two-dimensional array and a linear arrangement of six (identical) arrays on a carrier substrate are shown in FIG. 2.
- An array of measuring ranges for these examples comprises in each case an arrangement of measuring regions with 12 different samples applied in 4 replicates, the 4 identical measuring regions each being arranged in a common column perpendicular to the direction of propagation of the light guided during the detection step in the waveguiding layer of these carrier substrates ,
- the reproducibility of the measuring signals within the array of measuring ranges is to be determined with the help of the 4 identical measuring ranges.
- the analytical platform according to the invention in this example comprises 6 similar arrays of measuring ranges, as shown in FIG. 2.3. Passivation of the free areas between and within the measuring ranges
- the support substrates After application of the "naturally identical" samples and Cy5-BSA, the support substrates are dried in dust-free room air before the free, uncovered hydrophobic surface areas of the support substrates in a further step to minimize undesired non-specific binding of detection reagents, in this case antibodies and / or fluorescently labeled molecules, are saturated (passivated) with bovine serum albumin (BSA).
- detection reagents in this case antibodies and / or fluorescently labeled molecules
- a second assay step is carried out using an Alexa Fluor 647-labeled anti-rabbit Fab fragment (Molecular Probes, cat no Z-25308 , Leiden, The Netherlands), which binds to the aforementioned antibodies Al and A2.
- This fluorescently labeled Fab fragment is, starting from the commercially available stock solution, in a dilution of 1: 500 in assay buffer applied to the arrays (each 30 ul) and then for 1 hour at Room temperature incubated in the dark.
- the excitation wavelength in the measurements for the present example is 635 nm
- the detection of the fluorescent light with a cooled camera at the fluorescence wavelength of Cy5 using an interference filter (transmission (675 ⁇ 20) nm) for the suppression of scattered light at the excitation wavelength is positioned in front of the lens of the camera.
- the generated fluorescence images are automatically stored on the disk of the control computer. Further details of the optical system (ZeptoREADER TM) are described in International Patent Application PCT / EP01 / 10012, which is hereby incorporated in its entirety as part of this application.
- the raw data of the individual pixels of the camera represent a two-dimensional matrix of digitized measured values, with the measured intensity as the measured value of a single pixel corresponding to the area imaged on it on the sensor platform.
- a two-dimensional (coordinate) network is placed over the pixels (pixel values) in such a way that the partial image of each spot falls into an individual two-dimensional network element.
- each spot is assigned a circular area of interest (AOI) with a user-definable radius (typically 120 ⁇ m), which can be adjusted as well as the location of the individual AOIs individually as a function of the signal intensity of the individual
- the average radius signal intensity of each spot determines the arithmetic mean of the pixel values (signal intensities) within a selected evaluation range.
- the background signals are determined from the measured signal intensities between the spots.
- four further circular areas are defined per spot as evaluation areas for background signal determination, which are preferably arranged in the middle between between adjacent spots.
- the average background signal intensity is determined, for example, as the arithmetic mean of the pixel values (signal intensities) within an AOI selected for this purpose.
- the average net signal intensity from the measurement areas (spots) is then calculated as the difference between the local average gross and local mean background signal intensity of the respective spot.
- the referencing of the net signal intensity of all spots is done with the help of reference spots (Cy5-BSA) of each array of measuring ranges.
- the net signal intensity of each spot is divided by the average of the net signal intensities of the adjacent reference spots of the same row (arranged parallel to the propagation direction of the light guided in the evanescent field sensor platform).
- 3A shows a typical image of the fluorescence signals of a microarray according to an assay for the detection of p53, in which free areas between the measurement areas were passivated by means of the dipping method (according to 2.3.1.).
- the signal intensity within each individual reference spot and between different reference spots (Cy5-BSA) is distributed very evenly and homogeneously, and the edge of the almost perfectly circular spots is sharply delimited from the background (see detail image).
- the measuring ranges of the immobilized cell lysates are characterized by tail-like "smears", which is particularly noticeable at high signal intensities. As described above, these "smears" are caused during the moment of immersion of the carrier substrates provided with the spots into the passivation solution.
- sample components dissolved from the measurement areas by the passivation solution which are adsorbed along the flow in the opposite direction in the immediate vicinity of such a measurement area on the free, not yet passivated carrier substrate surface, before they even contain the BSA contained in the passivation solution can be passivated. Since these sample portions, which have been removed from the measurement areas and resorbed in the neighborhood, always contain a certain content of analyte to be detected, a corresponding fluorescence signal is visible on reading at said locations.
- 3B shows a typical image of the fluorescence signals of a microarray according to an assay for the detection of p53, in which free areas between the spots were passivated by means of the spray method (according to 2.3.2.).
- the signals from the reference spots are comparable in terms of their shape and uniformity or homogeneity as well as their intensity with those of a microarray after use of the dipping method.
- the signals from the measurement areas with immobilized cell lysates are also comparable in their intensity to the corresponding measurement signals from the microarrays which had been subjected to the immersion process.
- the cell lysate spots do not show the "smudges" described above, but only smaller "outgrowths” of lesser fluorescence intensity, which are evidently arranged approximately randomly around the intended spots. These are most likely caused by the local dissolution and outflow of non-bound cell lysate at the edges of the measurement areas, since the impinging small spray droplets of the passivation solution on impact with the surface have a non-negligible impulse perpendicular to the coating surface, which can lead to the generation of splashes.
- 3C shows a typical image of the fluorescence signals of a microarray according to an assay for the detection of p53, in which free areas between the measurement areas were passivated by means of the method according to the invention by fogging passivation solution, as described under 1. Striking here, compared to the passivated with the other methods described microarray, the high quality with comparably good homogeneity and shape of reference spots and Zellysatspots. "Smudges" or "outgrowths" of the cell lysate spots can be avoided here due to the fact, apart from the influence of gravity, essentially undirected and pulse-free application of the passivation in the form of fine mist droplets, the size of which is well below that produced by spraying droplets.
- the efficiency of passivation of the surface free of components from the immobilized sample i. the degree of suppression of nonspecific binding by means of the BSA contained in the passivation solution can be determined semiquantitatively from the signal intensity measured in the areas free of spots (between the spots, "background signals") nonspecific binding of the fluorescently labeled detection reagents (Alexa 647 anti-rabbit Fab) used in the assay to the BS A-free surface give a higher signal than a surface continuously coated with BSA.
- Figure 4A shows the averages and standard deviations of the background signal intensities determined between all spots of the free carrier substrate surfaces passivated by the three different methods with the microarrays generated thereon.
- the standard deviation of the background signal intensities after application of the spray method or the nebulization method according to the invention is in each case significantly lower than after use of the dipping method for surface passivation, which led to a standard deviation of the background signal intensities of 34%. It is concluded that the uniformity or homogeneity of the coating after application of the spraying or misting process is higher than after use of the dipping process.
- 4B shows the mean values of the fluorescence intensities of all reference spots of the microarrays, wherein the free surfaces of the associated carrier substrates were in turn treated with the three different coating methods.
- FIG. 5 A shows the average intensities and standard deviations of the fluorescence signals from the measuring ranges of the microarrays intended for analyte detection, the carrier substrate surfaces of which were each treated with the different passivation methods and which are subsequently treated with solutions of the antibody Al (anti-p53) (FIG. 5 A, top ) and A2 (anti-phospho-p53) (Figure 5A, bottom) and then each incubated for detection by fluorescence detection with Alexa 647 Fluor anti-rabbit F ab fragments.
- the measured fluorescence signal intensities correlate with the respective relative content of analytes contained in a cell lysate (corresponding to Zellysatkonzentration; higher signal corresponding to a higher analyte concentration, the correlation obviously being nonlinear in nature).
- Fig. 5B shows that the content of phospho-p53 in the UV-light-treated sample is also markedly increased compared to the control sample, while the content of phospho-p53 in the doxorubicin-treated sample, despite a massively increased total concentration of p53 only slightly above (in the case of lysate concentrations from 0.2 mg / ml to 0.4 mg / ml) or even below (in the case of the lysate concentration of 0.1 mg / ml) that of the control sample.
Landscapes
- Health & Medical Sciences (AREA)
- Clinical Laboratory Science (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Sampling And Sample Adjustment (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Application Of Or Painting With Fluid Materials (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH7352005 | 2005-04-26 | ||
| PCT/EP2006/003726 WO2006114249A1 (de) | 2005-04-26 | 2006-04-22 | Neue apparatur und verfahren zur beschichtung von trägersubstraten für einen analytnachweis mittels affinitäts-nachweisverfahren |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP1877773A1 true EP1877773A1 (de) | 2008-01-16 |
| EP1877773B1 EP1877773B1 (de) | 2014-10-15 |
Family
ID=36808724
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP06724515.9A Expired - Lifetime EP1877773B1 (de) | 2005-04-26 | 2006-04-22 | Neue apparatur und verfahren zur beschichtung von trägersubstraten für einen analytnachweis mittels affinitäts-nachweisverfahren |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9050615B2 (de) |
| EP (1) | EP1877773B1 (de) |
| JP (1) | JP5002584B2 (de) |
| CN (1) | CN101208599B (de) |
| AU (1) | AU2006239534B2 (de) |
| CA (1) | CA2605750A1 (de) |
| DK (1) | DK1877773T3 (de) |
| ES (1) | ES2525324T3 (de) |
| WO (1) | WO2006114249A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2485564A (en) * | 2010-11-18 | 2012-05-23 | Rolls Royce Plc | Luminescent surface coating for inspection |
| MX2013014553A (es) | 2011-06-30 | 2014-02-19 | Koninkl Philips Nv | Examenes multiples de una muestra. |
| US10545141B2 (en) | 2014-01-10 | 2020-01-28 | Konica Minolta, Inc. | Immunoassay method and immunoassay system |
| DE102014112625A1 (de) * | 2014-09-02 | 2016-03-03 | Schmid Energy Systems Gmbh | Großflächen-Ultraschallverdampfer |
| US10703843B2 (en) | 2014-12-08 | 2020-07-07 | University Of Virginia Patent Foundation | Compositions and methods for bonding glues, adhesives, and coatings to surfaces |
| CH712376A1 (de) | 2016-04-19 | 2017-10-31 | Camag | Derivatisierungsgerät und -verfahren. |
| CN106198952A (zh) * | 2016-07-01 | 2016-12-07 | 清华大学 | 一种抑制核酸分子对传感界面非特异性吸附的封闭方法 |
| CN107807133A (zh) * | 2017-11-08 | 2018-03-16 | 苏州安路特汽车部件有限公司 | 一种雾化渗透探伤装置 |
| CA3135206A1 (en) * | 2019-04-29 | 2020-11-05 | Pierre Indermuhle | Methods and systems for integrated on-chip single-molecule detection |
| US20240287316A1 (en) * | 2021-05-19 | 2024-08-29 | Swimc Llc | Metal packaging liquid or aerosol jet coating compositions, coated substrates, packaging, and methods |
| CN115147617B (zh) * | 2022-09-06 | 2022-11-22 | 聊城集众环保科技有限公司 | 基于计算机视觉的污水处理智能监控方法 |
| CN115837944A (zh) * | 2023-02-16 | 2023-03-24 | 太原理工大学 | 一种电厂烟气注入采空区防灾封存的气体监测装置 |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3514847A (en) * | 1966-05-10 | 1970-06-02 | Gen Dynamics Corp | Process for making photoconductive matrices |
| DE3380777D1 (en) | 1982-08-27 | 1989-11-30 | Roger Philip Ekins | Measurement of analyte concentration |
| JPS5955367A (ja) * | 1982-09-21 | 1984-03-30 | Tdk Corp | 静電防止剤塗布装置 |
| JPS6146028A (ja) * | 1984-08-10 | 1986-03-06 | Fujitsu Ltd | レジスト塗布装置 |
| US5807755A (en) | 1987-08-06 | 1998-09-15 | Multilyte Limited | Determination of ambient concentrations of several analytes |
| GB8803000D0 (en) | 1988-02-10 | 1988-03-09 | Ekins Roger Philip | Determination of ambient concentrations of several analytes |
| JPH01115450A (ja) * | 1987-10-28 | 1989-05-08 | Seiko Epson Corp | 潤滑層の形成方法 |
| US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| JPH03296460A (ja) * | 1990-04-13 | 1991-12-27 | Fujitsu General Ltd | フラックス塗付装置 |
| FR2669246A1 (fr) * | 1990-11-16 | 1992-05-22 | Centre Nat Rech Scient | Procede sol-gel de depot de couches minces par pulverisation ultrasonore. |
| EP1122540A3 (de) * | 1991-02-11 | 2001-11-07 | Biostar, Inc. | Verfahren zur Herstellung einer Testoberfläche zum optischen Nachweis eines biologischen Bindungsvorgangs |
| JPH06134367A (ja) * | 1992-04-10 | 1994-05-17 | Murata Mfg Co Ltd | 電子部品の外装構造 |
| IT1271969B (it) * | 1993-03-04 | 1997-06-10 | Mario Bonzi | Dispositivo per la umidificazione ed ionizzazione dell'aria |
| GB9326450D0 (en) | 1993-12-24 | 1994-02-23 | Multilyte Ltd | Binding assay |
| MXPA96005828A (es) | 1994-05-27 | 2005-07-15 | Novartis Ag Tambien Denominada | Proceso para detectar luminescencia excitada evanescentemente. |
| KR19990014709A (ko) | 1995-05-12 | 1999-02-25 | 한스루돌프하우스 | 센서 플랫폼 및 감쇠 여기된 발광을 이용한 복수 분석물의병렬 검출 방법 |
| WO1997002856A1 (en) | 1995-07-10 | 1997-01-30 | A & D Company, Limited | Handy atomizer |
| KR0144065B1 (ko) * | 1995-08-30 | 1998-08-01 | 배순훈 | 히터식 초음파 가습기 |
| US6143063A (en) * | 1996-03-04 | 2000-11-07 | Symetrix Corporation | Misted precursor deposition apparatus and method with improved mist and mist flow |
| WO1998009156A1 (en) | 1996-08-29 | 1998-03-05 | Novartis Ag | Optical chemical / biochemical sensor |
| US6045864A (en) * | 1997-12-01 | 2000-04-04 | 3M Innovative Properties Company | Vapor coating method |
| US6406921B1 (en) | 1998-07-14 | 2002-06-18 | Zyomyx, Incorporated | Protein arrays for high-throughput screening |
| DE60041255D1 (de) | 1999-04-28 | 2009-02-12 | Eidgenoess Tech Hochschule | Polyionische beschichtungen für analytische und sensor-vorrichtungen |
| JP2003508043A (ja) * | 1999-08-27 | 2003-03-04 | ピコグラム, インコーポレイテッド | 荷電されたミクロロケーションにおける操作を実行するための方法およびデバイス |
| US6510263B1 (en) | 2000-01-27 | 2003-01-21 | Unaxis Balzers Aktiengesellschaft | Waveguide plate and process for its production and microtitre plate |
| WO2001057254A2 (en) | 2000-02-02 | 2001-08-09 | Cartesian Technologies, Inc. | Method and apparatus for developing dna microarrays |
| AU2001262178A1 (en) | 2000-04-14 | 2001-10-30 | Zeptosens Ag | Grid-waveguide structure for reinforcing an excitation field and use thereof |
| JP2003533692A (ja) | 2000-05-06 | 2003-11-11 | ツェプトゼンス アクチエンゲゼルシャフト | 多重分析対象物測定及びその使用のための格子導波路構造 |
| AU2001289853A1 (en) | 2000-09-04 | 2002-03-22 | Zeptosens Ag | Multianalyte determination system and methods |
| US20040052489A1 (en) | 2001-04-02 | 2004-03-18 | Duveneck Gert Ludwig | Optical structure for multi-photon excitation and the use thereof |
| AU2002357547A1 (en) | 2001-12-13 | 2003-06-23 | Zeptosens Ag | Optically transparent substrate for a maldi measuring system and the use thereof |
| WO2004023142A1 (de) | 2002-09-03 | 2004-03-18 | Zeptosens Ag | Analytische plattform und nachweisverfahren mit den in einer probe nachzuweisenden analyten als immobilisierten spezifischen bindungspartnern |
| DE10320312A1 (de) | 2003-05-06 | 2004-12-02 | Friz Biochem Gmbh | Substrat als Träger von Ligaten |
| JP4318978B2 (ja) * | 2003-07-29 | 2009-08-26 | 独立行政法人科学技術振興機構 | 高分子固定化基板の製造方法およびこの方法により得られる高分子固定化基板 |
-
2006
- 2006-04-22 US US11/919,054 patent/US9050615B2/en not_active Expired - Fee Related
- 2006-04-22 DK DK06724515.9T patent/DK1877773T3/en active
- 2006-04-22 CA CA002605750A patent/CA2605750A1/en not_active Abandoned
- 2006-04-22 AU AU2006239534A patent/AU2006239534B2/en not_active Ceased
- 2006-04-22 ES ES06724515.9T patent/ES2525324T3/es not_active Expired - Lifetime
- 2006-04-22 CN CN200680023014.9A patent/CN101208599B/zh not_active Expired - Fee Related
- 2006-04-22 EP EP06724515.9A patent/EP1877773B1/de not_active Expired - Lifetime
- 2006-04-22 JP JP2008508125A patent/JP5002584B2/ja not_active Expired - Fee Related
- 2006-04-22 WO PCT/EP2006/003726 patent/WO2006114249A1/de not_active Ceased
Non-Patent Citations (1)
| Title |
|---|
| See references of WO2006114249A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| US9050615B2 (en) | 2015-06-09 |
| CN101208599A (zh) | 2008-06-25 |
| AU2006239534A1 (en) | 2006-11-02 |
| DK1877773T3 (en) | 2015-01-19 |
| WO2006114249A1 (de) | 2006-11-02 |
| ES2525324T3 (es) | 2014-12-22 |
| CN101208599B (zh) | 2014-12-10 |
| JP5002584B2 (ja) | 2012-08-15 |
| JP2008539399A (ja) | 2008-11-13 |
| CA2605750A1 (en) | 2006-11-02 |
| EP1877773B1 (de) | 2014-10-15 |
| AU2006239534B2 (en) | 2012-05-31 |
| US20090311773A1 (en) | 2009-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2001092870A2 (de) | Kit und verfahren zur multianalytbestimmung | |
| EP1877773B1 (de) | Neue apparatur und verfahren zur beschichtung von trägersubstraten für einen analytnachweis mittels affinitäts-nachweisverfahren | |
| EP1237654A1 (de) | Flusszellenanordnung und deren verwendung zur multianalytbestimmung | |
| EP1941276A1 (de) | Verfahren zur bestimmung eines oder mehrerer analyten in komplex zusammengesetzten proben biologischen ursprungs und dessen verwendung | |
| WO2002021110A1 (de) | System und verfahren zur multianalytbestimmung | |
| EP1274986A1 (de) | Vorrichtung und verfahren zur multianalytbestimmung | |
| EP1556695A2 (de) | Analytische plattform und nachweisverfahren mit gegebenenfalls nach fraktionierung in einer probe nachzuweisenden analyten als immobilisierten spezifischen bindungspartnern | |
| EP2324911A2 (de) | Prozessieren von Proben in Lösungen mit definiert kleiner Wandkontaktfläche | |
| DE60225593T2 (de) | Immobilisierung von bindungsstoffen | |
| WO2003096018A2 (de) | Kit zur assay-entwicklung und für serien-analysen | |
| CN1954213A (zh) | 用于产生细胞群体的蛋白表达谱的分析平台和方法 | |
| WO2002046756A1 (de) | Kit und verfahren zur multianalytbestimmung, mit vorkehrungen zur ortsaufgelösten referenzierung einer anregungslichtintensitaet | |
| EP2417436A1 (de) | Vorrichtung und verfahren zum nachweis und zur quantitativen analyse von analyten insbesondere mykotoxinen | |
| EP1561109A1 (de) | Analytische plattform und nachweisverfahren mit den in einer probe nachzuweisenden analyten als immobilisierten spezifischen bindungspartnern | |
| EP0905515A2 (de) | Analytisches Messverfahren und seine Verwendung | |
| DE102004021904B4 (de) | Verfahren und Vorrichtung zur Erzeugung einer Analyseanordnung mit diskreten, separaten Messbereichen zur biologischen, biochemischen oder chemischen Analyse | |
| WO2021122847A1 (de) | Träger für flüssigkeitstropfen | |
| WO2003020966A2 (de) | Oberfläche zur immobilisierung von nukleinsäuren | |
| DE102004034486B4 (de) | Verfahren zum Nachweis von Lumineszenzlicht aus einer porösen Trägerstruktur | |
| DE10312670A1 (de) | Substrat zur kontrollierten Benetzung vorbestimmter Benetzungsstellen mit kleinen Flüssigkeitsvolumina, Substratabdeckung und Flusskammer | |
| EP1963441A1 (de) | Polyelektrolyt mono- und multischichten für optische signalwandler | |
| DE20005738U1 (de) | Vorrichtung zur Untersuchung der molekularen Wechselwirkungen von löslichen oder suspendierbaren Wirkstoffen mit festphasen-gebundenen peptidischen oder peptoiden Zielmolekülen durch Kapillarplatten mit großer innerer Oberfläche | |
| WO2007090511A1 (de) | Polyelektrolyt mono- und multischichten für optische signalwandler |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20071126 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
| RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: UTINGER, DOMINIC Inventor name: SCHICK, EGINHARD Inventor name: CALONDER, CLAUDIO |
|
| RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: CALONDER, CLAUDIO Inventor name: SCHICK, EGINHARD Inventor name: UTINGER, DOMINIC |
|
| DAX | Request for extension of the european patent (deleted) | ||
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: BAYER INTELLECTUAL PROPERTY GMBH |
|
| 17Q | First examination report despatched |
Effective date: 20130617 |
|
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| INTG | Intention to grant announced |
Effective date: 20140708 |
|
| GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH Ref country code: CH Ref legal event code: EP |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: LANGUAGE OF EP DOCUMENT: GERMAN |
|
| REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 691904 Country of ref document: AT Kind code of ref document: T Effective date: 20141115 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 502006014018 Country of ref document: DE Effective date: 20141127 |
|
| REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2525324 Country of ref document: ES Kind code of ref document: T3 Effective date: 20141222 |
|
| REG | Reference to a national code |
Ref country code: DK Ref legal event code: T3 Effective date: 20150115 |
|
| REG | Reference to a national code |
Ref country code: SE Ref legal event code: TRGR |
|
| REG | Reference to a national code |
Ref country code: NL Ref legal event code: T3 |
|
| REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150215 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141015 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141015 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150216 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141015 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141015 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141015 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150116 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 502006014018 Country of ref document: DE |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141015 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141015 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141015 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141015 |
|
| PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
| 26N | No opposition filed |
Effective date: 20150716 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141015 Ref country code: LU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150422 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141015 |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 11 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20160323 Year of fee payment: 11 Ref country code: BE Payment date: 20160324 Year of fee payment: 11 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20160411 Year of fee payment: 11 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20160420 Year of fee payment: 11 Ref country code: DE Payment date: 20160419 Year of fee payment: 11 Ref country code: IE Payment date: 20160411 Year of fee payment: 11 Ref country code: ES Payment date: 20160331 Year of fee payment: 11 Ref country code: CH Payment date: 20160411 Year of fee payment: 11 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DK Payment date: 20160412 Year of fee payment: 11 Ref country code: AT Payment date: 20160330 Year of fee payment: 11 Ref country code: SE Payment date: 20160412 Year of fee payment: 11 Ref country code: IT Payment date: 20160418 Year of fee payment: 11 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20060422 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141015 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141015 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 502006014018 Country of ref document: DE |
|
| REG | Reference to a national code |
Ref country code: DK Ref legal event code: EBP Effective date: 20170430 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
| REG | Reference to a national code |
Ref country code: NL Ref legal event code: MM Effective date: 20170501 |
|
| REG | Reference to a national code |
Ref country code: AT Ref legal event code: MM01 Ref document number: 691904 Country of ref document: AT Kind code of ref document: T Effective date: 20170422 |
|
| GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20170422 |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20171229 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20171103 Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170422 Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170502 Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170501 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170423 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170430 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170430 Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170422 |
|
| REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20170430 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170430 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170422 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170430 Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170422 |
|
| REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20180703 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170423 |